Breast Cancer Research

Description

Breast Cancer

Search

Clinical Trials

Adjuvant (Alliance A191901) Temp Hold

STATUS: Active, Not Recruiting

Adjuvant Breast (EndoPredict Extended Endocrine Trial EXET Myriad)

STATUS: Active, Recruiting

Adjuvant (Alliance A011801 Compass HER2 Residual Disease)

STATUS: Active, Recruiting

City of Hope 96144 Molecular Genetics Studies of Cancer Patients and Their Relatives

STATUS: Active, Recruiting

Neoadjuvant (ECOG-ACRIN EA1181 Compass HER2 pCR)

STATUS: Active, Recruiting

View all Clinical Trials

Publications

Higher absolute lymphocyte counts predict lower mortality from early-stage triple-negative breast cancer.

Engaging patients in decisions about cancer screening: exploring the decision journey through the use of a patient portal.

Breast cancer chemoprevention in primary care - assessing readiness for change.

Adiposity, inflammation, genetic variants and risk of post-menopausal breast cancer findings from a prospective-specimen-collection, retrospective-blinded-evaluation (PRoBE) design approach.

Does the diagnosis of breast or ovarian cancer trigger referral to genetic counseling?

View all Publications

Research Studies

Impact of COVID-19 on Cancer Care Management

Breast Cancer Chemoprevention in Primary Care at Geisinger

Dana Farber 13-09-259 DCIS Registry

All Research Studies

Featured Investigator

Nitin Rohatgi

MD

Dr. Rohatgi is a research oncologist at SIMR.

Meet Nitin Rohatgi